Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

By Umemura Shigeki   Segawa Yoshihiko   Ueoka Hiroshi   Hotta Katsuyuki   Kiura Katsuyuki   Takigawa Nagio   Tabata Masahiro   Bessho Akihiro   Shinkai Tetsu   Tanimoto Mitsune  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 8, 2007-08 ,pp. : 519-524

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer

By Araujo Antonio   Mendez Jose   Coelho Ana   Sousa Berta   Barata Fernando   Figueiredo Ana   Amaro Teresina   Azevedo Isabel   Soares Marta  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite